{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T15:04:58Z","timestamp":1789311898612,"version":"build-2803163510"},"reference-count":30,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"DOI":"10.1080\/10428194.2026.2721033","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T14:49:15Z","timestamp":1789310955000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)\u2014a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US"],"prefix":"10.1080","author":[{"given":"Kelly","family":"Schoenbeck","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, University of California San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wei","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha C.","family":"Hazra","sequence":"additional","affiliation":[{"name":"Analysis Group ULC","place":["Montreal, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Ipsos, Geneva","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc.","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"Latremouille-Viau","sequence":"additional","affiliation":[{"name":"Analysis Group ULC","place":["Montreal, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Marquez","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Dublin","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Yang","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Damon","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Sadek","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Analysis Group ULC","place":["Montreal, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Clements","sequence":"additional","affiliation":[{"name":"CML Buster Foundation, Costa Mesa, CA","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"DeMairo","sequence":"additional","affiliation":[{"name":"Blood Cancer United, formerly The Leukemia & Lymphoma Society","place":["Washington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hiller","sequence":"additional","affiliation":[{"name":"Manton, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical College of Wisconsin","place":["Milwaukee, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,13]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27443"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.461"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02187-w"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01242-8"},{"issue":"2","key":"e_1_3_7_6_1","first-page":"105","article-title":"Response to therapy, treatment intolerance and tyrosine kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid leukaemia patients","volume":"88","author":"McMullan RR","year":"2019","unstructured":"McMullan RR, McConville C, McMullin MF. Response to therapy, treatment intolerance and tyrosine kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid leukaemia patients. Ulster Med J. 2019;88(2):105\u2013110.","journal-title":"Ulster Med J"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100825"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.170"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09451-4"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.03.2235"},{"key":"e_1_3_7_11_1","first-page":"PS2286","article-title":"Quality of life and work impacts among caregivers of patients with chronic myeloid leukemia (CML) - a caregiver survey in the US","volume":"4161360","author":"Flynn K","year":"2025","unstructured":"Flynn K, Clements J, DeMairo K, et\u00a0al. Quality of life and work impacts among caregivers of patients with chronic myeloid leukemia (CML) - a caregiver survey in the US. EHA Library. 2025;4161360:PS2286.","journal-title":"EHA Library"},{"key":"e_1_3_7_12_1","first-page":"PS2283","article-title":"Patient-physician communication regarding TKI-related adverse events and their impact on quality of life in CML - insights from patient and physician surveys in the US","volume":"4161357","author":"Flynn K","year":"2025","unstructured":"Flynn K, Schoenbeck K, DeMairo K, et\u00a0al. Patient-physician communication regarding TKI-related adverse events and their impact on quality of life in CML - insights from patient and physician surveys in the US. EHA Library. 2025;4161357:PS2283.","journal-title":"EHA Library"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju244"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9496-9"},{"key":"e_1_3_7_15_1","unstructured":"HealthMeasures. PROMIS\u00ae Global Health Scoring Manual. [cited 2025 Jul 15]. Available from: https:\/\/healthmeasures.net\/select-measures\/measure-library\/"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006"},{"key":"e_1_3_7_17_1","unstructured":"Reilly Associates. WPAI Scoring. [cited 2025 Jul 23]. Available from: http:\/\/www.reillyassociates.net\/WPAI_Scoring.html."},{"key":"e_1_3_7_18_1","unstructured":"HealthMeasures. Interpret Scores PROMIS\u00ae. [cited 2025 Jun 27]. Available from: https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis."},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00656-y"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347575"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-021-02925-y"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3549-5"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091585"},{"key":"e_1_3_7_24_1","doi-asserted-by":"crossref","unstructured":"Lundqvist I Gkitzia C Walsh S et\u00a0al. Clinical and humanistic burden in patients with chronic myeloid leukemia in early lines of treatment: a literature review. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024; 2024.","DOI":"10.1016\/j.jval.2024.10.3271"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1630-5"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.944973"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.104"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01154-0"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000969576.83189.62"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-5823.2010.00112.x"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq291"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2721033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10428194.2026.2721033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2721033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T14:49:17Z","timestamp":1789310957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2721033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,13]]},"references-count":30,"alternative-id":["10.1080\/10428194.2026.2721033"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2721033","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}